Allergic disease in children: integrated approach: Case

This boy has multisystem atopic disease spanning all four compartments: persistent severe eczema, IgE-mediated peanut allergy with prior anaphylaxis, poorly controlled asthma, and perennial allergic rhinitis. He illustrates the atopic march reaching adolescence, and the combination of food allergy with undertreated asthma in a teenager who is reluctant to carry his autoinjector places him squarely in the highest-risk group for fatal anaphylaxis. The clinical task is to build one coordinated plan that treats the tendency, optimises each organ, secures the food-allergy safety net, and engages an adolescent who is at the developmental stage where risk-taking peaks. ^[5][6]

Clinical findings

The key findings are the four-organ pattern and the risk markers within it. The eczema is widespread and sleep-disrupting, indicating uncontrolled disease and a high sensitisation load. The peanut history is the defining risk: a documented anaphylaxis at three years, a persistent large skin-prick wheal, and sensitisation to Ara h 2, the stable storage protein that predicts systemic rather than cross-reactive, pollen-related allergy. The asthma is poorly controlled, with frequent short-acting bronchodilator use and two oral-steroid courses in a year, and poor asthma control in a food-allergic child is the single clearest predictor of fatal food anaphylaxis because the anaphylactic bronchospasm compounds an already twitchy airway. ^[6]

The candidate should articulate the problem representation: a 12-year-old with multisystem atopic disease and a prior peanut anaphylaxis, with poorly controlled asthma and adolescent barriers to autoinjector adherence, requiring an integrated plan that prioritises anaphylaxis safety, asthma control, skin control, and adolescent engagement. The candidate should also name the risk explicitly: this is a prototypical fatality-risk profile. ^[4]